Cargando…
A Case of Advanced Submandibular Gland Cancer in Which Increased Prostate-Specific Antigen and Multiple Bone Metastases Wrongly Suggested Concurrent Prostate Cancer
A 73-year-old man, followed for prostatic hyperplasia, developed submandibular gland cancer. Initially, because of the concurrent presence of elevated serum prostate-specific antigen (PSA) and multiple bone metastases, he was clinically determined as having stage IV prostate cancer in addition to st...
Autores principales: | Fukasawa, Yoko, Honda, Takeshi, Natsume, Maika, Haruyama, Terunobu, Ishihara, Masashi, Sakamoto, Takahiko, Usui, Ryo, Tanzawa, Shigeru, Ota, Shuji, Ichikawa, Yasuko, Watanabe, Kiyotaka, Saito, Koji, Seki, Nobuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803733/ https://www.ncbi.nlm.nih.gov/pubmed/29430238 http://dx.doi.org/10.1159/000484975 |
Ejemplares similares
-
A Case of Lung Adenocarcinoma with Marked Improvement of Pulmonary Lymphangitic Carcinomatosis by Adding Bevacizumab to Cisplatin and Pemetrexed
por: Natsume, Maika, et al.
Publicado: (2017) -
A Case of Paraneoplastic Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Improved by Chemotherapy
por: Sakamoto, Takahiko, et al.
Publicado: (2017) -
A Patient with Advanced Gastric Cancer Who Achieved a Long-Term Prognosis by Early Diagnosis of Sister Mary Joseph's Nodule
por: Ota, Shuji, et al.
Publicado: (2018) -
Paraneoplastic IgA Vasculitis in an Adult with Lung Adenocarcinoma
por: Ota, Shuji, et al.
Publicado: (2017) -
Promising Combination Therapy with Bevacizumab and Erlotinib in an EGFR-Mutated NSCLC Patient with MET Amplification Who Showed Intrinsic Resistance to Initial EGFR-TKI Therapy
por: Seki, Nobuhiko, et al.
Publicado: (2019)